This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_BILIARY_TRACT_EXALLC for full statistics.
Malignant neoplasm of other and unspecified parts of biliary tract
C3_BILIARY_TRACT
biliary tract neoplasm: A neoplasm that involves the biliary tract.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
446 |
4. Check minimum number of eventsNone |
446 |
5. Include endpointsNone |
446 |
6. Filter based on genotype QC (FinnGen only) |
446 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of other and unspecified parts of biliary tract
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of other and unspecified parts of biliary tract, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder
- Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of digestive organs
- Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 446 | 181 | 265 |
| Unadjusted period prevalence (%) | 0.09 | 0.06 | 0.12 |
| Median age at first event (years) | 71.37 | 70.69 | 71.84 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 394
- Matched controls
- 3937
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
130
Kela drug reimbursment
Malignant tumour
31.2
169.1
247
201
C24.9
ICD-10 Finland
Malignant neoplasm: Biliary tract, unspecified
970.1
142.3
131
*
K83.1
ICD-10 Finland
Obstruction of bile duct
118.6
128.2
134
17
UJK02
NOMESCO Finland
ERCP
42.1
106.2
133
47
JLC30
NOMESCO Finland
Pancreatoduodenectomy
234.4
105.1
104
6
R17
ICD-10 Finland
Hyperbilirubinaemia, with or without jaundice, not elsewhere classified
56.2
101.3
119
30
JKE18
NOMESCO Finland
Endoscopic internal drainage of bile duct
140.8
100.7
104
10
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
57.6
88.1
103
24
A03FA01
ATC
metoclopramide; systemic, rectal
9.0
82.2
225
508
C24.1
ICD-10 Finland
Malignant neoplasm: Ampulla of Vater
+∞
81.1
75
*
8160/3-C24.9
ICD-O-3
Cholangiocarcinoma of billiary tract, NOS
+∞
81.1
75
*
C22.1
ICD-10 Finland
Malignant neoplasm: Intrahepatic bile duct carcinoma
100.9
81.0
87
11
Z51.5
ICD-10 Finland
Palliative care
14.4
75.3
137
140
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
43.1
75.1
93
28
N02AA05
ATC
oxycodone; systemic
8.4
71.5
194
409
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
20.2
70.3
109
73
C24.0
ICD-10 Finland
Malignant neoplasm: Extrahepatic bile duct
+∞
69.9
65
*
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
49.8
66.7
80
20
A04AA02
ATC
granisetron; systemic, transdermal
15.1
66.6
117
107
A09AA02
ATC
multienzymes (lipase, protease etc.)
29.9
65.6
89
38
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
44.6
64.4
79
22
L01BC06
ATC
capecitabine; oral
21.3
62.2
94
57
H02AB02
ATC
dexamethasone; systemic
9.9
61.3
137
201
8140/3-C24.1
ICD-O-3
Adenocarcinoma, NOS, of ampulla of Vater
+∞
58.8
55
*
C24.09
ICD-10 Finland
Biliary duct or passage NOS
+∞
56.6
53
*
JKE02
NOMESCO Finland
Transduodenal endoscopic incision of common bile duct orifice
30.1
56.4
76
31
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
18.6
55.0
87
59
C24.00
ICD-10 Finland
Hepatic duct
+∞
53.4
50
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
13.7
52.6
95
89
C24.02
ICD-10 Finland
Common bile duct
+∞
51.2
48
*
JK3BT
NOMESCO Finland
Catherisation of bile duct with X-ray guidance
122.1
50.2
53
5
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
22.9
49.3
72
38
8160/3-C24.0
ICD-O-3
Cholangiocarcinoma of extrahepatic bile duct
+∞
49.0
46
*
8000/3-C24.9
ICD-O-3
Neoplasm, malignant of billiary tract, NOS
+∞
49.0
46
*
K83.0
ICD-10 Finland
Cholangitis
29.7
48.2
65
26
JL5SB
NOMESCO Finland
Endoscopic retrograd cholangiopancreaticography
28.0
46.7
64
27
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
24.3
43.4
62
30
8140/3-C24.0
ICD-O-3
Adenocarcinoma, NOS, of extrahepatic bile duct
+∞
41.4
39
*
8000/3-C24.0
ICD-O-3
Neoplasm, malignant of extrahepatic bile duct
+∞
38.1
36
*
JN4CD
NOMESCO Finland
Very extensive body CT
11.6
36.9
71
73
JN4BD
NOMESCO Finland
Extensive body CT
6.1
36.7
112
240
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
12.6
36.3
67
63
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
6.8
33.2
91
167
C24.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of biliary tract
+∞
32.8
31
*
JAH01
NOMESCO Finland
Laparoscopy
13.4
31.0
55
47
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
11.0
30.7
60
63
JN3BD
NOMESCO Finland
Extensive abdominal CT
5.5
30.5
100
229
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
8.0
28.7
68
100
JKE22
NOMESCO Finland
Endoscopic extraction of foreign body from bile duct
69.4
28.4
32
5
JK3NB
NOMESCO Finland
Percutaneous transhepatic cholangiography
156.1
28.0
29
*
TPH04
NOMESCO Finland
Cathetrisation of vein
3.8
27.6
143
510
R50.9
ICD-10 Finland
Fever, unspecified
4.3
27.3
117
351
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
7.3
27.0
68
109
JK3FT
NOMESCO Finland
Exchange of bile duct catheter with radiological guidance
+∞
26.3
25
*
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
15.4
26.0
43
31
JK4ZT
NOMESCO Finland
Percutaneous transhepatic implantation of bile duct prothesis
100.3
26.0
28
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.5
25.8
104
292
8140/3-C24.9
ICD-O-3
Adenocarcinoma, NOS, of billiary tract, NOS
+∞
24.2
23
*
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
9.1
23.8
51
63
JN4AD
NOMESCO Finland
Body CT examination
5.4
23.4
75
164
A04AA01
ATC
ondansetron; systemic, rectal
6.6
23.3
63
111
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.1
23.2
168
753
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.1
22.9
101
306
WZC30
NOMESCO Finland
Teaching
4.3
22.2
92
262
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
31.2
22.2
29
10
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
5.6
21.2
65
134
JN3AD
NOMESCO Finland
Abdominal CT examination
5.4
21.0
67
145
C23
ICD-10 Finland
Malignant neoplasm of gallbladder
81.3
20.9
23
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
7.0
20.4
52
84
JKE32
NOMESCO Finland
Endoscopic dilatation of bile duct
50.9
20.4
24
5
B01AB10
ATC
tinzaparin; parenteral
5.6
19.1
58
118
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
40.6
18.8
23
6
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
7.4
18.7
45
67
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
20.6
18.5
27
14
K83.9
ICD-10 Finland
Disease of biliary tract, unspecified
46.4
18.4
22
5
C22.9
ICD-10 Finland
Malignant neoplasm: Liver, unspecified
23.1
18.4
26
12
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
11.5
18.3
34
32
R4190
NOMESCO Finland
Nutritional therapy
10.0
18.1
36
39
B01AB05
ATC
enoxaparin; parenteral
2.7
18.0
166
835
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
8.5
17.8
39
50
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
14.0
17.7
30
23
TPH07
NOMESCO Finland
Cathetrisation of artery
3.8
16.3
74
225
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
27.6
15.8
21
8
TPX10
NOMESCO Finland
Implantation of vascular injection port
8.5
15.2
33
42
A06AH03
ATC
naloxegol; oral
14.9
14.7
24
17
JKE25
NOMESCO Finland
Endoscopic external drainage of bile duct
83.3
14.7
16
*
A04AA55
ATC
palonosetron, combinations; systemic
8.9
14.3
30
36
WX402
NOMESCO Finland
General anaesthesia
3.3
14.3
80
286
J01MA12
ATC
levofloxacin; systemic
2.7
14.0
115
526
C24.01
ICD-10 Finland
Cystic duct
+∞
13.6
13
*
JK3NT
NOMESCO Finland
Percutaneous transhepatic dilatation of bileducts
144.8
13.5
14
*
A02BC02
ATC
pantoprazole; systemic
2.3
12.9
273
1963
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
12.2
12.5
22
19
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
5.8
12.4
35
65
JAH00
NOMESCO Finland
Laparotomy
6.5
12.4
32
53
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
10.5
12.2
23
23
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.8
12.0
83
339
C17.0
ICD-10 Finland
Malignant neoplasm: Duodenum
67.0
11.7
13
*
R18
ICD-10 Finland
Ascites
9.3
11.4
23
26
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
36.2
11.3
14
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.3
11.2
123
647
A05AA02
ATC
ursodeoxycholic acid; oral
11.0
10.9
20
19
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.6
10.7
89
403
JKA20
NOMESCO Finland
Cholecystectomy
6.2
10.6
28
48
D77
ICPC
Malignant digestive neopl other/NOS
16.6
10.4
16
10
JDE00
NOMESCO Finland
Gastrojejunostomy
33.5
10.4
13
*
UJK12
NOMESCO Finland
Peroral cholangioscopy
24.1
10.3
14
6
WX004
NOMESCO Finland
Patient-controlled sedation
24.1
10.3
14
6
A06AD11
ATC
lactulose; oral
2.4
10.2
101
499
C22.0
ICD-10 Finland
Malignant neoplasm: Liver cell carcinoma
11.7
10.2
18
16
JK3SB
NOMESCO Finland
Endoscopic retrorade cholangiography
41.2
10.0
12
*
WW500
NOMESCO Finland
Blood transfusion
4.9
9.6
31
68
D76
ICPC
Malignant neoplasm pancreas
102.4
9.5
10
*
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
6.5
9.2
23
37
K90.3
ICD-10 Finland
Pancreatic steatorrhoea
19.1
9.0
13
7
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.4
8.8
84
403
A98
ICPC
Health maint/preventive medicine
0.5
8.8
241
2981
R93.2
ICD-10 Finland
Abnormal findings on diagnostic imaging of liver and biliary tract
51.1
8.7
10
*
JKC30
NOMESCO Finland
Partial excision of bile duct and anastomosis to jejunum
+∞
8.4
8
*
A04AD12
ATC
aprepitant; systemic
6.7
8.3
20
31
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
22.6
8.1
11
5
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
15.4
7.8
12
8
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
15.4
7.8
12
8
K80.5
ICD-10 Finland
Calculus of bile duct without cholangitis or cholecystitis
4.7
7.7
25
56
XJD02
NOMESCO Finland
Peroral endoscopic ultrasonography
12.2
7.6
13
11
8160/3-C22.1
ICD-O-3
Cholangiocarcinoma of intrahepatic bile duct
25.6
7.6
10
*
K76.9
ICD-10 Finland
Liver disease, unspecified
10.3
7.6
14
14
ZXE40
NOMESCO Finland
More than seven and less than nine hours
5.8
7.5
20
36
K85.8
ICD-10 Finland
Other acute pancreatitis
13.7
7.4
12
9
JKE12
NOMESCO Finland
Endoscopic extraction of calculus from bile duct
7.1
7.4
17
25
JK3MB
NOMESCO Finland
Postoperative cholangiography
+∞
7.3
7
*
WX892
NOMESCO Finland
Monitored bed care
2.8
7.1
45
174
WX725
NOMESCO Finland
Noninvasive ventilation
3.9
6.9
27
73
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.1
6.9
36
123
ZX120
NOMESCO Finland
Intravenous
2.6
6.7
49
204
JA3BT
NOMESCO Finland
Cathetrisation of abdominal cavity with X-ray guidance
23.0
6.7
9
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
4.8
6.7
21
46
K83.8
ICD-10 Finland
Other specified diseases of biliary tract
71.0
6.4
7
*
JL5CG
NOMESCO Finland
Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet
14.6
6.4
10
7
XX3DW
NOMESCO Finland
Time consuming IT work
2.5
6.4
51
225
8163/3-C24.1
ICD-O-3
Pancreatobiliary type carcinoma of ampulla of Vater
+∞
6.3
6
*
C25.7
ICD-10 Finland
Malignant neoplasm: Other parts of pancreas
+∞
6.3
6
*
D13
ICPC
Jaundice
+∞
6.3
6
*
WX002
NOMESCO Finland
Sedation and analgesia
2.0
6.2
86
486
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
4.7
6.1
19
42
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
269
440
13.89
181.92
7.2
4.2
ug/l
48.4
35.1
0.20
252
374
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
175
166
16.70
172.07
7.2
3.1
u/ml
4457.0
1869.4
0.35
165
144
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
83
32
31.64
122.91
1.4
1.2
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
163
361
6.54
75.43
5.1
2.0
g/l
0.2
0.2
6.28
155
337
(3000570) Elastase.pancreatic [Mass/mass] in Stool
84
92
11.02
71.91
1.6
1.5
ug/g
112.7
288.4
9.07
51
56
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
166
409
5.87
67.70
8.9
2.8
umol/l
50.9
8.4
8.07
154
362
(40768441) Liver Pathology biopsy report
48
29
18.43
58.17
1.4
1.2
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
267
1112
4.49
54.09
8.7
2.5
u/l
58.7
56.8
0.15
259
1031
(3023368) Bacteria identified in Blood by Culture
234
1129
3.26
33.24
9.2
4.3
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
222
1057
3.19
31.95
9.4
3.2
u/l
67.9
33.4
8.64
212
1004
(3012095) Magnesium [Moles/volume] in Serum or Plasma
154
591
3.45
31.77
4.8
3.5
mmol/l
0.8
0.8
5.03
147
546
(3032080) INR in Blood by Coagulation assay
280
1587
3.05
28.53
16.1
10.2
inr
1.3
1.3
0.29
81
443
(4035726)
101
322
3.76
27.31
1.5
1.4
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
280
1622
2.95
26.77
15.0
4.6
g/l
30.1
34.8
28.92
274
1500
(3020779) Urea [Moles/volume] in Serum or Plasma
95
336
3.32
21.54
6.8
7.0
mmol/l
8.2
10.7
2.10
90
321
(3042936) Bacteria identified in Isolate by Culture
130
555
2.89
21.24
2.6
2.0
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
30
49
6.49
17.89
2.3
1.2
g/l
1.1
0.8
0.54
20
39
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
16
11
15.05
17.70
1.4
3.7
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
39
95
4.40
14.97
3.5
3.0
umol/l
36.0
33.7
0.26
33
78
(3044640) Blood type and Crossmatch panel - Blood
188
1119
2.18
13.92
3.9
2.4
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
69
259
2.97
13.84
1.6
1.6
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
23
38
6.33
13.52
2.5
3.3
nmol/l
2.9
8.2
0.68
23
38
(3015377) Calcium [Moles/volume] in Serum or Plasma
192
1219
2.01
11.40
9.0
3.3
mmol/l
2.3
2.3
0.80
180
1051
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
41
128
3.43
11.12
3.1
2.9
u/ml
0.3
0.3
0.73
22
68
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
233
1593
1.97
11.08
6.9
4.1
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
268
1935
1.96
10.72
24.3
8.9
e9/l
4.7
4.2
2.23
253
1694
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
223
2944
0.51
10.64
3.9
4.6
mu/l
2.2
2.0
0.88
184
2604
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
59
234
2.75
10.61
1.8
1.4
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
130
741
2.06
10.21
11.0
3.1
mmol/l
2.5
2.5
4.36
122
648
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
142
838
2.02
10.12
3.5
2.4
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
34
102
3.53
9.79
1.7
1.6
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
35
901
0.34
9.44
1.4
1.6
mmol/l
1.4
1.3
0.06
29
743
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
264
3263
0.53
9.25
4.0
5.4
mmol/l
2.5
2.6
1.67
220
2939
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
248
1816
1.82
8.76
9.4
6.8
mmol/l
1.2
1.2
3.29
200
1526
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
113
647
2.00
8.59
2.0
1.9
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
173
2393
0.55
8.55
3.5
3.7
pmol/l
15.0
15.1
0.01
134
2112
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
264
1989
1.80
8.30
8.4
3.2
u/l
301.1
55.1
15.67
244
1825
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
255
3149
0.56
8.21
3.8
4.7
mmol/l
1.3
1.4
4.85
210
2833
(3010421) pH of Blood
31
99
3.29
8.12
5.1
3.8
ph
7.4
7.4
1.00
31
80
(1616796) Gas panel - Central venous blood
26
74
3.67
8.09
2.3
2.9
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
263
3213
0.56
8.02
4.5
5.0
mmol/l
6.3
6.1
1.70
220
2879
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
259
3176
0.56
7.97
3.8
4.8
mmol/l
4.3
4.5
1.52
218
2884
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
19
43
4.57
7.97
1.1
1.0
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
228
1662
1.76
7.88
8.3
6.1
mmol/l
1.2
1.2
4.82
219
1497
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
50
215
2.49
7.62
12.3
9.5
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
20
49
4.23
7.62
1.1
1.0
—
—
—
0
0
(3026782) Osmolality of Urine
123
759
1.86
7.35
3.0
3.1
mosm/kgh2o
578.3
564.7
0.24
107
644
(3003694) ABO and Rh group [Type] in Blood
129
809
1.84
7.32
1.4
1.3
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
254
3104
0.58
7.24
7.8
6.5
mmol/mol
42.6
40.9
1.76
223
2844
(3017143) Hepatitis C virus Ab [Presence] in Serum
57
275
2.23
6.71
1.3
1.5
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
18
45
4.13
6.68
2.1
1.9
%
91.8
88.9
1.89
18
45
(40768797) Stomach Pathology biopsy report
83
464
1.97
6.63
1.4
1.2
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
252
3052
0.60
6.40
3.6
4.2
mmol/l
1.3
1.3
0.18
210
2720
(42870588) Differential panel, method unspecified - Blood
161
1120
1.68
6.20
4.5
5.5
—
—
—
0
0
(3019060) Gas panel - Arterial blood
58
292
2.13
6.14
6.8
4.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
81
461
1.93
6.12
1.8
1.9
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
80
456
1.92
6.02
1.9
1.8
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
56
281
2.14
5.98
1.3
1.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
72
400
1.95
5.83
5.5
3.6
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
83
484
1.88
5.82
9.3
7.4
kpa
13.9
11.6
3.64
78
467
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
14
32
4.48
5.80
1.9
3.0
u/ml
86.8
67.6
0.16
14
32
(3003396) Base excess in Arterial blood by calculation
83
486
1.87
5.74
9.3
7.4
mmol/l
0.6
1.3
0.93
65
387
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
104
1534
0.58
5.54
4.2
5.3
ug/l
1.9
3.3
1.83
85
1356
(3013005) Retinol [Moles/volume] in Serum or Plasma
9
8
11.45
5.31
1.8
1.5
umol/l
1.9
1.9
—
9
8
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
17
49
3.57
5.22
1.0
1.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
79
1237
0.56
5.17
3.9
4.6
%
20.6
21.4
0.22
40
637
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
50
896
0.50
5.10
2.9
3.1
ug/l
0.6
0.8
3.19
34
621
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
11
23
4.88
5.04
2.0
1.0
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
86
530
1.77
5.01
2.5
2.4
%
19.7
21.9
0.79
78
455
(3028026) IgM [Mass/volume] in Serum or Plasma
42
202
2.19
4.99
1.5
1.6
g/l
1.6
1.7
0.03
36
185
(3000850) Epithelial cells [#/volume] in Urine
117
789
1.65
4.90
2.8
2.7
e6/l
6.8
4.4
1.16
104
697
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
181
1359
1.56
4.83
3.6
3.3
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
48
247
2.06
4.81
2.4
2.4
g/l
11.2
10.0
1.07
40
221
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
264
3090
0.64
4.80
42.1
15.9
ml/min/173m2
80.9
74.0
6.40
235
2554
(3002582) Erythrocytes [#/volume] in Urine
157
1150
1.56
4.64
3.5
3.5
e6/l
48.3
133.1
0.83
136
888
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
9
11
8.32
4.58
5.2
1.9
%
100.1
96.5
—
9
11
(1761868) Lipid panel - Serum or Plasma
61
995
0.55
4.51
2.9
3.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
19
65
3.01
4.50
1.1
1.2
—
—
—
0
0
(3018418) pH of Serum or Plasma
151
1106
1.55
4.42
5.1
4.2
ph
7.4
7.4
3.53
46
202
(3004789) Transferrin [Mass/volume] in Serum or Plasma
86
549
1.70
4.40
2.5
2.4
g/l
2.3
2.3
0.10
80
505
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
9
12
7.63
4.37
1.8
1.4
umol/l
32.1
29.5
—
9
12
(3010813) Leukocytes [#/volume] in Blood
320
3564
0.64
4.17
61.2
24.5
e9/l
8.1
6.8
11.65
313
3446
(3000963) Hemoglobin [Mass/volume] in Blood
320
3564
0.64
4.17
61.7
24.6
g/l
117.9
133.8
54.79
313
3494
(3026361) Erythrocytes [#/volume] in Blood
320
3564
0.64
4.17
61.2
24.4
e12/l
4.0
4.4
37.71
311
3445
(3035941) MCH [Entitic mass]
320
3563
0.64
4.15
61.0
24.3
pg
30.0
30.5
4.75
314
3500
(3024731) MCV [Entitic volume]
320
3563
0.64
4.15
61.0
24.3
fl
90.7
91.7
3.47
314
3501
(3007461) Platelets [#/volume] in Blood
320
3562
0.64
4.13
61.3
24.4
e9/l
262.9
239.5
5.85
311
3459
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
16
52
3.15
4.12
1.4
1.6
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
9
14
6.54
4.00
2.0
1.7
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
11
28
4.00
4.00
3.6
3.3
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
309
2669
1.51
3.91
31.5
7.6
u/l
222.1
80.1
21.68
304
2484
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
0
98
0.00
3.90
0.0
1.5
—
2.8
—
0
71
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
117
1577
0.65
3.86
2.5
2.3
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
200
1590
1.47
3.83
5.3
5.8
%
19.1
26.4
17.25
190
1470
(3020891) Body temperature
32
155
2.15
3.77
4.3
4.8
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
134
986
1.51
3.75
3.6
3.3
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
51
293
1.84
3.73
4.1
4.0
%
0.8
0.9
0.31
29
99
(3018095) Leukocytes [#/volume] in Urine
168
1296
1.48
3.73
3.9
4.0
e6/l
61.1
153.0
0.96
144
951
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
15
50
3.07
3.72
1.0
1.6
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
15
50
3.07
3.72
1.1
1.7
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
172
1343
1.46
3.55
3.0
2.2
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
138
1035
1.48
3.49
3.6
3.4
e6/l
0.7
0.6
0.18
119
783
(3002256) Pathology report gross observation
69
442
1.66
3.47
1.5
1.3
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
16
58
2.82
3.45
1.4
1.6
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
13
42
3.16
3.39
3.2
2.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
7
10
7.09
3.37
1.0
1.2
—
—
—
0
0
(4062490)
10
27
3.77
3.37
1.7
1.1
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
44
253
1.82
3.23
4.2
4.2
%
0.1
0.1
0.15
24
74
(3012544) pH of Venous blood
60
379
1.67
3.19
3.8
3.9
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
46
270
1.78
3.16
4.4
4.1
%
0.1
0.1
0.47
26
88
(3002179) Metamyelocytes/100 leukocytes in Blood
44
255
1.80
3.15
4.3
3.9
%
0.9
0.4
0.91
22
68
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
6
8
7.58
3.06
1.0
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
6
8
7.58
3.06
1.0
1.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
13
45
2.95
3.05
2.7
3.9
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
21
94
2.30
3.01
1.5
1.6
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
192
1568
1.39
2.96
5.1
5.5
%
64.8
58.2
10.30
183
1460
(3019069) Monocytes/100 leukocytes in Blood
192
1568
1.39
2.96
5.4
5.9
%
8.7
8.9
0.36
181
1463
(3022096) Basophils/100 leukocytes in Blood
187
1522
1.39
2.93
5.1
5.6
%
0.4
0.6
9.61
175
1416
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
18
76
2.43
2.93
1.6
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
18
76
2.43
2.93
1.6
1.3
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
6
9
6.74
2.87
2.0
7.3
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
315
3454
0.70
2.85
33.9
11.1
u/l
44.0
25.1
14.46
310
3316
(3019198) Lymphocytes [#/volume] in Blood
203
1682
1.38
2.83
5.0
5.4
e9/l
1.4
1.9
6.35
182
1481
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
16
65
2.52
2.82
1.4
1.6
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
10
31
3.28
2.79
1.7
1.6
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
46
282
1.70
2.74
1.7
1.6
%
1.5
1.6
0.90
41
243
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
14
54
2.64
2.73
1.2
1.4
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
20
92
2.23
2.71
1.6
1.6
—
—
—
0
0
(3024471) HLA-A [Type]
6
10
6.06
2.70
1.2
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
6
10
6.06
2.70
1.2
1.1
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
8
19
4.27
2.69
2.4
4.0
nmol/l
68.5
100.7
—
8
19
(3000494) Fungus identified in Specimen by Culture
62
413
1.58
2.68
1.8
1.4
—
—
—
0
0
(40758558) Short blood count panel - Blood
113
854
1.43
2.67
18.8
6.6
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
318
3465
0.71
2.57
48.2
20.1
mmol/l
4.0
4.0
3.20
312
3370
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
12
44
2.78
2.56
1.4
1.5
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
188
1559
1.36
2.53
5.3
5.6
%
2.0
2.8
7.39
177
1449
(3019550) Sodium [Moles/volume] in Serum or Plasma
318
3459
0.72
2.47
48.2
20.0
mmol/l
137.2
139.7
29.95
312
3364
(3004775) Volume in Urine collected for unspecified duration
10
34
2.99
2.42
3.4
2.6
ml
724.0
605.7
—
5
21
(40761536) Microorganisms panel - Urine sediment
45
284
1.65
2.42
4.2
4.1
—
—
—
0
0
(3036489) Thrombin time
22
111
2.03
2.40
2.4
2.1
s
22.0
22.0
0.00
22
106
(3051611) Lipemic interference index of Serum or Plasma
11
40
2.79
2.39
3.6
3.3
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
55
367
1.57
2.37
3.7
3.9
mmol/l
1.3
1.8
0.44
45
293
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
84
1115
0.70
2.33
2.0
2.1
u/l
164.6
285.2
0.92
77
1051
(3025941) Bacteria identified in Stool by Culture
28
157
1.84
2.27
1.1
1.2
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
196
1656
1.33
2.26
5.0
5.4
e9/l
0.0
0.0
3.02
169
1435
(3031040) Bacteria [#/volume] in Urine by Automated count
262
2309
1.33
2.24
5.3
4.9
e6/l
2.2
3929.8
—
5
52
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
13
54
2.45
2.21
1.7
1.6
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
11
42
2.66
2.20
1.5
1.6
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
27
152
1.83
2.17
2.0
1.8
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
7
19
3.73
2.16
1.4
1.6
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
194
1646
1.32
2.15
5.0
5.3
e9/l
0.6
0.6
0.69
170
1417
(40761511) CBC panel - Blood by Automated count
308
3345
0.74
2.14
43.6
16.0
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
15
68
2.25
2.13
1.7
1.7
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
7
20
3.54
2.06
1.4
1.6
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
199
1704
1.30
2.03
5.0
5.5
e9/l
0.1
0.2
4.06
173
1493
(3025468) Yersinia sp identified in Specimen by Organism specific culture
11
44
2.54
2.02
1.5
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
11
44
2.54
2.02
1.5
1.5
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
12
51
2.39
1.96
1.4
1.6
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
14
64
2.23
1.96
2.9
3.2
%
65.8
58.3
1.35
14
64
(3005988) Vibrio sp identified in Specimen by Organism specific culture
11
45
2.48
1.94
1.5
1.5
—
—
—
0
0
(3000991) Gas panel - Venous blood
48
327
1.52
1.91
9.6
9.2
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
23
3.08
1.80
1.4
1.6
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
13
61
2.17
1.73
2.1
2.5
e9/l
5.6
4.6
0.26
13
61
(3033799) Differential panel - Peritoneal fluid
5
13
3.88
1.72
1.6
1.8
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
10
42
2.41
1.69
1.7
1.7
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
8
31
2.61
1.66
2.0
2.5
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
11
49
2.28
1.65
1.3
3.5
—
875.4
—
0
5
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
5
14
3.60
1.62
1.0
1.1
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
89
1110
0.75
1.62
3.1
3.2
mg/l
55.9
224.0
1.05
56
732
(3017732) Neutrophils [#/volume] in Blood
32
209
1.57
1.56
4.7
2.8
e9/l
5.5
3.8
1.21
27
151
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
10
44
2.30
1.54
1.5
1.5
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
71
546
1.36
1.51
20.5
27.0
inr
1.8
1.4
—
8
69
(3009508) Creatinine [Moles/volume] in Urine
91
1121
0.76
1.50
2.9
3.1
mmol/l
8.3
7.4
1.00
63
919
(3026493) Urate [Moles/volume] in Serum or Plasma
73
926
0.75
1.49
2.5
2.8
umol/l
352.6
9913.5
5.23
57
782
(3021960) Folate [Moles/volume] in Serum or Plasma
72
913
0.75
1.46
1.6
1.6
nmol/l
19.2
20.6
0.42
67
762
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
9
38
2.40
1.46
1.2
1.7
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
91
731
1.31
1.44
4.2
4.1
ng/l
888.7
342.8
0.30
74
615
(40760892) CBC W Ordered Manual Differential panel - Blood
84
671
1.31
1.39
4.0
4.8
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
6
23
2.63
1.37
1.0
1.0
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
5
17
2.96
1.36
1.0
1.0
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
173
1513
1.23
1.35
4.2
4.1
ng/l
24.6
64.9
1.24
145
1165
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
34
482
0.68
1.35
1.3
1.3
iu/ml
87.1
43.2
—
9
157
(3009466) Valproate [Moles/volume] in Serum or Plasma
0
40
0.00
1.33
0.0
4.1
—
363.9
—
0
32
(3026389) Candida sp identified in Specimen by Organism specific culture
9
43
2.12
1.31
1.0
1.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
77
614
1.31
1.29
3.1
3.2
e6/l
3.8
2.0
0.47
50
355
(3020682) Albumin/Creatinine [Ratio] in Urine
99
1178
0.79
1.22
3.9
3.9
mg/mmol
8.7
9.0
0.02
60
750
(4281824)
8
37
2.18
1.22
1.5
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
22
141
1.59
1.19
1.9
1.6
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
110
928
1.25
1.18
2.4
2.1
mg/l
3.6
3.2
0.35
96
800
(3015235) Bicarbonate [Moles/volume] in Capillary blood
5
114
0.43
1.14
1.2
2.1
mmol/l
23.3
24.8
—
5
93
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
46
599
0.74
1.13
1.2
1.2
u/ml
7.3
1.3
—
7
163
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
17
104
1.66
1.11
1.2
1.3
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
7
31
2.28
1.11
1.0
1.1
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
18
112
1.63
1.10
3.8
3.5
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
10
178
0.55
1.05
1.1
1.3
—
36.9
—
0
13
(3004451) EKG impression Narrative
5
22
2.29
1.03
1.2
1.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
5
107
0.46
1.02
1.2
1.5
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
229
2479
0.84
1.02
4.3
4.2
mm/h
23.8
14.3
7.70
204
2241
(3045414) Leukocytes [Presence] in Urine
7
134
0.51
1.00
1.3
2.0
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
34
454
0.73
0.99
1.2
1.3
u/ml
1.5
16.7
3.25
12
159
(3017817) Protein [Mass] in Urine collected for unspecified duration
0
31
0.00
0.96
0.0
3.0
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
9
52
1.75
0.93
1.1
1.5
g/l
37.2
32.8
—
9
47
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
14
86
1.65
0.92
1.9
1.5
—
—
—
0
0
(3044889) 12 lead EKG panel
225
2425
0.85
0.90
5.0
4.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
5
105
0.47
0.89
1.8
1.6
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
29
2.08
0.89
1.0
1.1
—
—
—
0
0
(44790048)
8
42
1.92
0.89
1.4
1.6
—
—
—
0
0
(44806118)
8
42
1.92
0.89
1.4
1.6
—
—
—
0
0
(44790047)
8
42
1.92
0.89
1.4
1.6
—
—
—
0
0
(44790049)
8
42
1.92
0.89
1.4
1.6
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
13
79
1.66
0.89
1.4
1.4
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
131
1158
1.19
0.88
2.7
3.4
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
247
2639
0.86
0.87
54.9
20.5
%
15.1
13.9
22.74
247
2585
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
8
44
1.83
0.86
1.9
1.6
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
104
902
1.20
0.86
3.8
3.9
—
—
—
0
0
(3022313) Gas panel - Capillary blood
26
188
1.41
0.85
3.1
3.8
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
35
451
0.76
0.83
4.0
4.8
%
33.7
31.7
0.36
21
291
(21494755) Public health laboratory ask at order entry panel
9
149
0.60
0.80
1.4
1.4
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
24
0.00
0.79
0.0
1.5
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
24
0.00
0.79
0.0
1.5
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
53
432
1.26
0.79
1.9
1.6
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
11
66
1.68
0.79
1.5
2.6
%
62.1
61.1
0.05
11
66
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
0
25
0.00
0.79
0.0
2.9
—
40.8
—
0
8
(3028626) Oxygen [Partial pressure] in Capillary blood
5
96
0.52
0.79
1.2
2.1
kpa
8.4
7.7
—
5
83
(4024509)
0
28
0.00
0.76
0.0
1.3
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
13
83
1.58
0.75
2.8
3.0
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
22
299
0.72
0.75
1.8
1.5
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
139
1536
0.86
0.74
2.0
2.1
pmol/l
85.3
93.3
1.14
79
804
(3012441) Differential panel - Pleural fluid
7
41
1.72
0.70
1.1
1.4
—
—
—
0
0
(4034850)
7
120
0.58
0.68
17.6
11.6
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
141
1279
1.15
0.67
4.2
4.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
5
94
0.53
0.67
1.0
1.4
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
16
111
1.46
0.67
3.6
2.7
ug/min
90.0
100.1
—
8
64
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
5
29
1.73
0.64
1.0
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
5
30
1.67
0.61
2.0
2.3
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
5
30
1.67
0.61
1.0
1.2
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
0
20
0.00
0.60
0.0
1.1
—
1.2
—
0
12
(3044941) Cell count panel - Synovial fluid
8
52
1.55
0.59
1.6
1.5
—
—
—
0
0
(3022621) pH of Urine by Test strip
19
253
0.74
0.59
3.7
3.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
13
89
1.47
0.58
1.2
1.3
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
0
23
0.00
0.58
0.0
1.1
—
57.7
—
0
17
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
315
3264
0.88
0.57
47.2
16.8
mg/l
44.6
26.1
13.53
307
2671
(3019832) Treponema pallidum Ab [Presence] in Serum
5
86
0.58
0.56
1.0
1.5
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
45
377
1.22
0.56
1.5
1.3
titre
502.9
395.8
—
7
86
(3042631) Mycobacterium sp identified in Specimen
9
60
1.51
0.54
2.2
3.3
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
6
38
1.59
0.54
1.5
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
6
38
1.59
0.54
1.5
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
6
38
1.59
0.54
1.5
1.6
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
11
158
0.69
0.53
1.1
2.0
—
—
—
0
0
(40768443) Skin Pathology biopsy report
11
157
0.69
0.52
1.1
1.3
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
9
64
1.41
0.51
3.0
2.7
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
21
267
0.78
0.49
1.6
2.2
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
7
46
1.53
0.48
1.3
1.6
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
25
200
1.26
0.47
3.6
3.1
mmol/l
23.5
25.1
1.01
25
195
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
37
438
0.83
0.47
16.8
8.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
13
175
0.74
0.45
1.1
1.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
23
285
0.80
0.45
1.5
1.4
—
—
—
0
0
(3000492) Spirometry study
20
252
0.78
0.44
1.2
1.5
—
—
—
0
0
(3011648) Oxygen content in Venous blood
5
32
1.57
0.42
1.6
2.0
%
13.3
10.6
—
5
32
(3003181) Sodium [Moles/volume] in Urine
10
70
1.44
0.42
1.3
1.3
mmol/l
61.6
64.2
—
5
61
(3019225) pH of Specimen
40
343
1.18
0.41
5.8
4.1
—
—
—
0
0
(4306422)
5
33
1.52
0.41
1.4
1.3
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
245
2349
1.10
0.41
4.9
4.6
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
(4211845)
0
17
0.00
0.40
0.0
3.5
—
—
—
0
0
(44813793)
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
1.8
—
809.7
—
0
17
(3011288) Drugs identified in Urine by Screen method
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
5
34
1.48
0.40
1.4
1.5
—
—
—
0
0
(4027681)
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
5
35
1.43
0.39
1.6
2.3
—
3.5
—
0
10
(46235355) HIV 1 and 2 tests - Meaningful Use set
37
317
1.18
0.39
1.2
1.5
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
11
80
1.38
0.38
1.5
1.2
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
29
243
1.21
0.38
3.1
3.6
mmol/l
2.4
2.0
0.15
20
184
(3029937) Albumin [Presence] in Urine by Test strip
100
921
1.11
0.38
4.5
4.4
estimate
0.0
0.0
0.00
38
296
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
5
37
1.36
0.37
1.4
1.1
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
6
41
1.47
0.36
1.5
1.8
—
—
—
0
0
(3013512) EKG study
120
1120
1.10
0.36
4.1
4.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
5
79
0.63
0.36
11.4
3.8
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
9
123
0.73
0.35
1.0
1.0
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
6
43
1.40
0.35
1.5
1.7
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
15
189
0.79
0.35
1.2
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
29
339
0.85
0.34
1.3
1.3
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
6
90
0.66
0.33
1.2
1.7
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
75
817
0.90
0.33
1.6
1.8
pmol/l
493.0
6006446.2
0.50
60
666
(1761482) Bacteria [#/volume] in Urine by Culture
16
128
1.26
0.32
4.1
5.1
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
70
640
1.11
0.31
3.1
3.0
e6/l
1.2
1.1
0.09
43
376
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
7
56
1.25
0.29
1.1
1.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
273
2806
0.93
0.29
40.1
18.3
%
33.0
38.9
9.52
162
1805
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
8
62
1.30
0.28
1.0
1.4
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
5
72
0.69
0.26
1.2
1.3
mg/l
422.0
541.1
—
5
65
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
17
142
1.20
0.25
2.5
3.3
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
120
1262
0.93
0.24
4.3
3.2
ng/l
1297.4
1746.2
0.65
105
1091
(3035350) Ketones [Presence] in Urine by Test strip
169
1628
1.06
0.22
4.0
4.2
estimate
0.0
0.0
0.00
46
308
(3007164) IgA [Mass/volume] in Serum or Plasma
60
556
1.09
0.22
1.5
1.4
g/l
2.7
2.7
0.03
39
325
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
6.6
—
0.7
—
0
10
(3000285) Sodium [Moles/volume] in Blood
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
135
1294
1.06
0.21
2.8
2.6
ug/l
215.7
153.0
1.27
125
1175
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
2.1
—
2.4
—
0
6
(3008536) Aspergillus sp Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
12
0.00
0.21
0.0
1.2
—
9.5
—
0
12
(3036670) Protein [Mass/volume] in Synovial fluid
0
13
0.00
0.21
0.0
1.3
—
39.4
—
0
8
(3000919) Neutrophils/100 leukocytes in Pleural fluid
0
13
0.00
0.21
0.0
1.1
—
33.6
—
0
8
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
14
0.00
0.20
0.0
4.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
6
52
1.16
0.19
1.0
1.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
5
67
0.74
0.17
1.8
1.5
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
5
67
0.74
0.17
2.0
1.7
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
15
173
0.86
0.17
1.9
2.9
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
151
1464
1.05
0.16
25.9
10.2
e9/l
0.0
0.0
0.20
120
1202
(3003327) Ova and parasites identified in Stool by Light microscopy
8
73
1.10
0.16
2.1
1.4
—
—
—
0
0
(3022145) Colonoscopy Study observation
36
389
0.92
0.15
1.9
1.3
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
69
726
0.94
0.15
3.6
1.7
mg/l
3.5
1.4
1.32
60
570
(3011397) Hemoglobin [Presence] in Urine by Test strip
73
766
0.94
0.15
3.7
4.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
9
83
1.09
0.14
1.7
1.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
13
112
1.17
0.14
1.3
1.3
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
168
1638
1.04
0.14
5.1
5.6
estimate
0.0
0.0
0.00
46
306
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
8
99
0.80
0.13
1.4
1.4
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
26
282
0.92
0.12
3.6
3.0
ml/min/173m2
68.3
59.6
0.72
12
114
(4010399)
22
238
0.92
0.10
1.2
1.5
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
10
87
1.15
0.09
1.0
2.1
g/l
108.8
128.1
—
5
61
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
5
62
0.80
0.08
1.2
1.3
mmol/l
4.7
3.9
—
5
55
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
5
63
0.79
0.08
1.8
2.5
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
10
88
1.14
0.08
1.6
1.8
e6/l
11129.2
22786.4
—
5
63
(3009261) Glucose [Presence] in Urine by Test strip
169
1663
1.03
0.08
4.1
4.2
estimate
0.0
0.0
0.00
44
301
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
19
204
0.93
0.07
2.3
2.6
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
35
334
1.05
0.07
2.0
2.6
e9/l
66.7
70.7
0.23
25
270
(3019150) Specific gravity of Urine by Refractometry
71
730
0.97
0.07
4.5
4.7
kg/l
1.0
1.0
0.22
16
121
(42529406) Shigella sp [Presence] in Stool by Culture
8
91
0.88
0.07
1.1
1.2
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
9
104
0.86
0.06
1.2
1.6
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
19
178
1.07
0.05
1.2
1.4
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
78
795
0.98
0.04
2.0
1.7
nmol/l
1249.6
1181.8
0.24
64
606
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
27
279
0.97
0.02
2.3
3.9
ng/l
66.1
85.7
1.45
27
248
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
134
1352
0.99
0.02
2.3
2.2
nmol/l
67.5
78.0
4.02
126
1175
(3048689) Calprotectin [Mass/mass] in Stool
31
303
1.02
0.01
2.5
2.1
ug/g
234.8
143.2
0.51
25
239
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
12
126
0.95
0.00
1.4
1.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
31
304
1.02
0.00
3.9
3.6
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
24
244
0.98
0.00
1.6
1.6
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
10
98
1.02
0.00
1.0
1.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
21
208
1.01
0.00
3.5
4.3
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
10
99
1.01
0.00
1.2
1.0
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
46
465
0.99
0.00
2.1
2.5
%
1.9
1.8
0.25
38
419
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
7
0.00
0.00
0.0
1.3
—
1.3
—
0
7
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
60
1.00
0.00
1.0
1.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
5
54
0.93
0.00
1.4
1.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
5
57
0.88
0.00
1.0
2.6
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
8
0.00
0.00
0.0
1.0
—
3.5
—
0
8
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
8
0.00
0.00
0.0
6.1
—
7.2
—
0
8
(3005011) Chlamydia sp Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
8
79
1.01
0.00
1.0
1.3
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
9
0.00
0.00
0.0
1.0
—
18.3
—
0
9
(3025315) Body weight
0
5
0.00
0.00
0.0
3.8
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
8
89
0.90
0.00
1.1
1.2
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
5
52
0.96
0.00
1.4
1.1
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
8
89
0.90
0.00
1.1
1.2
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
9
96
0.94
0.00
1.3
1.2
—
2.1
—
0
9
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_BILIARY_TRACT – Malignant neoplasm of other and unspecified parts of biliary tract
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).